admera_health_final_logo_transparent_final.jpg
Chinese-Based MedCDx and US-Based Admera Health Enter Into Strategic Partnership to Co-Develop Companion Diagnostics
February 26, 2019 09:21 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Today, MedCDx and Admera Health announced a non-exclusive collaborative agreement. Under the terms of the agreement, MedCDx (formerly Qiagen...
Leading-Edge Microbi
Leading-Edge Microbiome Discovery Platform Receives New Funding
February 25, 2019 09:17 ET | Phase Genomics
SEATTLE, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Phase Genomics, the leader in proximity ligation-based genomic solutions, announced today a year-long grant awarded by the Bill & Melinda Gates...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results
January 14, 2019 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report...
®_Bionano_RGB.jpg
Global Adoption of Bionano Genomics’ Saphyr® System Accelerating for Clinical Genomics Applications
January 14, 2019 08:00 ET | Bionano Genomics
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr system, which enables ultra-sensitive...
Fibrocor, a MaRS Inn
Fibrocor, a MaRS Innovation portfolio company, announces deal with Galapagos
January 07, 2019 10:43 ET | MaRS Innovation
Toronto, ON, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Fibrocor Therapeutics, a privately held Canadian company, and Galapagos NV, a Belgo-Dutch pharmaceutical research company, have announced the formation...
B. Braun CeGaT, LLC logo
CeGaT receives California CLIA State License and Accreditation - expanding diagnostic services in California
January 02, 2019 16:00 ET | B. Braun CeGaT, LLC
BETHLEHEM, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- CeGaT GmbH is a CLIA certified laboratory for high complexity testing (CLIA# 99D2130225) approved by US authorities (Centers of Medicare &...
LogoPressRelease.jpg
Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares
December 14, 2018 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the closing of its...
20181212_ORB_Active-Motif_Press_Image
Improved Accuracy and Speed for Disease Research, Two Genomic Companies Integrate Kits and Software to Enable Deep Exploration of Epigenetic Data
December 12, 2018 15:16 ET | OnRamp BioInformatics, Inc.
SAN DIEGO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- OnRamp BioInformatics, a genomics company focused on scientist-friendly bioinformatics software solutions, today announced they are working with Active...
LogoPressRelease.jpg
Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock
December 12, 2018 01:01 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an...
LogoPressRelease.jpg
Fluidigm Announces Commencement of Public Offering of Common Stock
December 11, 2018 16:01 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced that it intends to...